Global Genome Engineering Editing Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04253514

Publication Date:

April 28, 2025

Pages:

120

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Genome Engineering Editing market size is predicted to grow from US$ 9542 million in 2025 to US$ 27320 million in 2031; it is expected to grow at a CAGR of 19.2% from 2025 to 2031.
Genome Engineering Editing is a modern molecular biology technology that involves targeted modifications to the genome of an organism to change the sequence of a target gene or regulate its expression. This technology is largely based on genome editing tools such as CRISPR-Cas9, which allows scientists to precisely add, delete or replace an organism's genes.
Global key players of Genome Engineering Editing include Thermo Fisher Scientific, AstraZeneca, SIGMA ALDRICH, Agilent Technologies, Illumina, etc. The top five players hold a share over 52%. North America is the largest market, and has a share about 37%, followed by Asia-Pacific and Europe with share 25% and 18%, separately. In terms of product type, CRISPR RNP is the largest segment, occupied for a share of 39%. In terms of application, GMP has a share about 70 percent.
The 鈥淕enome Engineering Editing Industry Forecast鈥� looks at past sales and reviews total world Genome Engineering Editing sales in 2024, providing a comprehensive analysis by region and market sector of projected Genome Engineering Editing sales for 2025 through 2031. With Genome Engineering Editing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genome Engineering Editing industry.
This Insight Report provides a comprehensive analysis of the global Genome Engineering Editing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genome Engineering Editing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Genome Engineering Editing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genome Engineering Editing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genome Engineering Editing.
This report presents a comprehensive overview, market shares, and growth opportunities of Genome Engineering Editing market by product type, application, key players and key regions and countries.
Segmentation by Type:
CRISPR RNP
CRISPR mRNA
CRISPR Virus Delivery
Others
Segmentation by Application:
RUO
GMP
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon锛圚orizo鈥嬧€媙 Discovery锛�
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
Illumina
Editas Medicine
Agilent Technologies
QIAGEN NV

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Genome Engineering Editing Market Size (2020-2031)
2.1.2 Genome Engineering Editing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Genome Engineering Editing by Country/Region (2020, 2024 & 2031)
2.2 Genome Engineering Editing Segment by Type
2.2.1 CRISPR RNP
2.2.2 CRISPR mRNA
2.2.3 CRISPR Virus Delivery
2.2.4 Others
2.3 Genome Engineering Editing Market Size by Type
2.3.1 Genome Engineering Editing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Genome Engineering Editing Market Size Market Share by Type (2020-2025)
2.4 Genome Engineering Editing Segment by Application
2.4.1 RUO
2.4.2 GMP
2.5 Genome Engineering Editing Market Size by Application
2.5.1 Genome Engineering Editing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Genome Engineering Editing Market Size Market Share by Application (2020-2025)
3 Genome Engineering Editing Market Size by Player
3.1 Genome Engineering Editing Market Size Market Share by Player
3.1.1 Global Genome Engineering Editing Revenue by Player (2020-2025)
3.1.2 Global Genome Engineering Editing Revenue Market Share by Player (2020-2025)
3.2 Global Genome Engineering Editing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Genome Engineering Editing by Region
4.1 Genome Engineering Editing Market Size by Region (2020-2025)
4.2 Global Genome Engineering Editing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Genome Engineering Editing Market Size Growth (2020-2025)
4.4 APAC Genome Engineering Editing Market Size Growth (2020-2025)
4.5 Europe Genome Engineering Editing Market Size Growth (2020-2025)
4.6 Middle East & Africa Genome Engineering Editing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Genome Engineering Editing Market Size by Country (2020-2025)
5.2 Americas Genome Engineering Editing Market Size by Type (2020-2025)
5.3 Americas Genome Engineering Editing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genome Engineering Editing Market Size by Region (2020-2025)
6.2 APAC Genome Engineering Editing Market Size by Type (2020-2025)
6.3 APAC Genome Engineering Editing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Genome Engineering Editing Market Size by Country (2020-2025)
7.2 Europe Genome Engineering Editing Market Size by Type (2020-2025)
7.3 Europe Genome Engineering Editing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Genome Engineering Editing by Region (2020-2025)
8.2 Middle East & Africa Genome Engineering Editing Market Size by Type (2020-2025)
8.3 Middle East & Africa Genome Engineering Editing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Genome Engineering Editing Market Forecast
10.1 Global Genome Engineering Editing Forecast by Region (2026-2031)
10.1.1 Global Genome Engineering Editing Forecast by Region (2026-2031)
10.1.2 Americas Genome Engineering Editing Forecast
10.1.3 APAC Genome Engineering Editing Forecast
10.1.4 Europe Genome Engineering Editing Forecast
10.1.5 Middle East & Africa Genome Engineering Editing Forecast
10.2 Americas Genome Engineering Editing Forecast by Country (2026-2031)
10.2.1 United States Market Genome Engineering Editing Forecast
10.2.2 Canada Market Genome Engineering Editing Forecast
10.2.3 Mexico Market Genome Engineering Editing Forecast
10.2.4 Brazil Market Genome Engineering Editing Forecast
10.3 APAC Genome Engineering Editing Forecast by Region (2026-2031)
10.3.1 China Genome Engineering Editing Market Forecast
10.3.2 Japan Market Genome Engineering Editing Forecast
10.3.3 Korea Market Genome Engineering Editing Forecast
10.3.4 Southeast Asia Market Genome Engineering Editing Forecast
10.3.5 India Market Genome Engineering Editing Forecast
10.3.6 Australia Market Genome Engineering Editing Forecast
10.4 Europe Genome Engineering Editing Forecast by Country (2026-2031)
10.4.1 Germany Market Genome Engineering Editing Forecast
10.4.2 France Market Genome Engineering Editing Forecast
10.4.3 UK Market Genome Engineering Editing Forecast
10.4.4 Italy Market Genome Engineering Editing Forecast
10.4.5 Russia Market Genome Engineering Editing Forecast
10.5 Middle East & Africa Genome Engineering Editing Forecast by Region (2026-2031)
10.5.1 Egypt Market Genome Engineering Editing Forecast
10.5.2 South Africa Market Genome Engineering Editing Forecast
10.5.3 Israel Market Genome Engineering Editing Forecast
10.5.4 Turkey Market Genome Engineering Editing Forecast
10.6 Global Genome Engineering Editing Forecast by Type (2026-2031)
10.7 Global Genome Engineering Editing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Genome Engineering Editing Forecast
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Genome Engineering Editing Product Offered
11.1.3 Thermo Fisher Scientific Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 SIGMA ALDRICH
11.2.1 SIGMA ALDRICH Company Information
11.2.2 SIGMA ALDRICH Genome Engineering Editing Product Offered
11.2.3 SIGMA ALDRICH Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 SIGMA ALDRICH Main Business Overview
11.2.5 SIGMA ALDRICH Latest Developments
11.3 Dharmacon锛圚orizo鈥嬧€媙 Discovery锛�
11.3.1 Dharmacon锛圚orizo鈥嬧€媙 Discovery锛� Company Information
11.3.2 Dharmacon锛圚orizo鈥嬧€媙 Discovery锛� Genome Engineering Editing Product Offered
11.3.3 Dharmacon锛圚orizo鈥嬧€媙 Discovery锛� Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Dharmacon锛圚orizo鈥嬧€媙 Discovery锛� Main Business Overview
11.3.5 Dharmacon锛圚orizo鈥嬧€媙 Discovery锛� Latest Developments
11.4 Cellectics
11.4.1 Cellectics Company Information
11.4.2 Cellectics Genome Engineering Editing Product Offered
11.4.3 Cellectics Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Cellectics Main Business Overview
11.4.5 Cellectics Latest Developments
11.5 CRISPR Therapeutics
11.5.1 CRISPR Therapeutics Company Information
11.5.2 CRISPR Therapeutics Genome Engineering Editing Product Offered
11.5.3 CRISPR Therapeutics Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 CRISPR Therapeutics Main Business Overview
11.5.5 CRISPR Therapeutics Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Genome Engineering Editing Product Offered
11.6.3 AstraZeneca Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Bio Rad
11.7.1 Bio Rad Company Information
11.7.2 Bio Rad Genome Engineering Editing Product Offered
11.7.3 Bio Rad Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bio Rad Main Business Overview
11.7.5 Bio Rad Latest Developments
11.8 Allele Biotech
11.8.1 Allele Biotech Company Information
11.8.2 Allele Biotech Genome Engineering Editing Product Offered
11.8.3 Allele Biotech Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Allele Biotech Main Business Overview
11.8.5 Allele Biotech Latest Developments
11.9 Recombinetics
11.9.1 Recombinetics Company Information
11.9.2 Recombinetics Genome Engineering Editing Product Offered
11.9.3 Recombinetics Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Recombinetics Main Business Overview
11.9.5 Recombinetics Latest Developments
11.10 Lonza
11.10.1 Lonza Company Information
11.10.2 Lonza Genome Engineering Editing Product Offered
11.10.3 Lonza Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Lonza Main Business Overview
11.10.5 Lonza Latest Developments
11.11 Illumina
11.11.1 Illumina Company Information
11.11.2 Illumina Genome Engineering Editing Product Offered
11.11.3 Illumina Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Illumina Main Business Overview
11.11.5 Illumina Latest Developments
11.12 Editas Medicine
11.12.1 Editas Medicine Company Information
11.12.2 Editas Medicine Genome Engineering Editing Product Offered
11.12.3 Editas Medicine Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Editas Medicine Main Business Overview
11.12.5 Editas Medicine Latest Developments
11.13 Agilent Technologies
11.13.1 Agilent Technologies Company Information
11.13.2 Agilent Technologies Genome Engineering Editing Product Offered
11.13.3 Agilent Technologies Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Agilent Technologies Main Business Overview
11.13.5 Agilent Technologies Latest Developments
11.14 QIAGEN NV
11.14.1 QIAGEN NV Company Information
11.14.2 QIAGEN NV Genome Engineering Editing Product Offered
11.14.3 QIAGEN NV Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 QIAGEN NV Main Business Overview
11.14.5 QIAGEN NV Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂